loading
Precedente Chiudi:
$9.99
Aprire:
$9.74
Volume 24 ore:
146.46K
Relative Volume:
0.16
Capitalizzazione di mercato:
$742.58M
Reddito:
$54.55M
Utile/perdita netta:
$-193.57M
Rapporto P/E:
-3.3737
EPS:
-2.89
Flusso di cassa netto:
$-181.86M
1 W Prestazione:
+1.88%
1M Prestazione:
-16.11%
6M Prestazione:
-55.83%
1 anno Prestazione:
-35.79%
Intervallo 1D:
Value
$9.545
$9.86
Intervallo di 1 settimana:
Value
$9.25
$10.14
Portata 52W:
Value
$8.18
$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Name
Nome
Nurix Therapeutics Inc
Name
Telefono
(415) 660-5320
Name
Indirizzo
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Name
Dipendente
286
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-09
Name
Ultimi documenti SEC
Name
NRIX's Discussions on Twitter

Confronta NRIX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NRIX
Nurix Therapeutics Inc
9.74 721.19M 54.55M -193.57M -181.86M -2.89
Biotechnology icon
ONC
Beigene Ltd Adr
241.97 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.93 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.31 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.51 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.05 5.92B 0 -153.72M -103.81M -2.00

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-17 Iniziato Leerink Partners Market Perform
2024-12-10 Iniziato BTIG Research Buy
2024-12-06 Iniziato BMO Capital Markets Outperform
2024-10-24 Iniziato UBS Buy
2024-10-11 Iniziato Jefferies Buy
2024-09-06 Ripresa Robert W. Baird Outperform
2024-07-31 Iniziato Truist Buy
2023-06-26 Ripresa Oppenheimer Outperform
2023-03-09 Iniziato Barclays Overweight
2023-02-28 Iniziato Oppenheimer Outperform
2022-10-11 Iniziato Morgan Stanley Equal-Weight
2022-05-31 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-02-10 Iniziato Wells Fargo Equal Weight
2021-12-29 Iniziato H.C. Wainwright Buy
2021-10-14 Iniziato SVB Leerink Outperform
2021-06-04 Ripresa Robert W. Baird Outperform
2021-04-30 Ripresa Piper Sandler Overweight
2021-04-30 Iniziato RBC Capital Mkts Outperform
2021-04-14 Iniziato Berenberg Buy
2020-11-19 Iniziato Robert W. Baird Outperform
2020-08-18 Iniziato JP Morgan Overweight
2020-08-18 Iniziato Needham Buy
2020-08-18 Iniziato Piper Sandler Overweight
2020-08-18 Iniziato Stifel Buy
Mostra tutto

Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie

pulisher
May 21, 2025

Deutsche Bank AG Sells 323,485 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Soleus Capital Management L.P. Has $39.62 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

97,889 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by Velan Capital Investment Management LP - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Vestal Point Capital LP Purchases 60,000 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Northern Trust Corp Grows Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 21, 2025
pulisher
May 20, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Jacobs Levy Equity Management Inc. Buys Shares of 229,369 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Point72 Asset Management L.P. Makes New $16.45 Million Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 20, 2025
pulisher
May 19, 2025

Nurix Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

May 19, 2025
pulisher
May 19, 2025

Nurix Therapeutics reports stockholder voting results - Investing.com

May 19, 2025
pulisher
May 19, 2025

Ensign Peak Advisors Inc Acquires 194,673 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is Patient Square Capital LP's 6th Largest Position - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Parkman Healthcare Partners LLC Has $10.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 19, 2025
pulisher
May 17, 2025

Cubist Systematic Strategies LLC Acquires Shares of 124,025 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 17, 2025
pulisher
May 17, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Integral Health Asset Management LLC - MarketBeat

May 17, 2025
pulisher
May 16, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listin - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 16, 2025
pulisher
May 16, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 15, 2025

Nurix CFO and CBO to Share Latest Company Updates at Major RBC Healthcare Conference Next Week - Stock Titan

May 15, 2025
pulisher
May 14, 2025

Nurix Therapeutics Announces Presentations of Clinical Data at t - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Nurix Therapeutics to Present Phase 1a/b Clinical Trial Data on Bexobrutideg (NX-5948) for CLL and Waldenström Macroglobulinemia at EHA 2025 and 18-ICML Conferences - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Breakthrough Blood Cancer Treatment: Nurix's BTK Degrader Shows Promising Clinical Results in CLL Patients - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Where are the Opportunities in (NRIX) - news.stocktradersdaily.com

May 13, 2025
pulisher
May 13, 2025

Why Nurix Therapeutics (NRIX) Is Among the Best Low Priced Biotech Stocks to Buy Now - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

10 Best Low Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

Shareholders Will Probably Hold Off On Increasing Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) CEO Compensation For The Time Being - simplywall.st

May 12, 2025
pulisher
May 12, 2025

Voya Investment Management LLC Acquires 34,811 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 12, 2025
pulisher
May 10, 2025

135,903 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by First Trust Advisors LP - MarketBeat

May 10, 2025
pulisher
May 10, 2025

Raymond James Financial Inc. Takes $1.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 10, 2025
pulisher
May 09, 2025

Deep Track Capital LP Sells 868,104 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 09, 2025
pulisher
May 07, 2025

Invesco Ltd. Decreases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Boxer Capital Management LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 07, 2025
pulisher
May 06, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by JPMorgan Chase & Co. - MarketBeat

May 06, 2025
pulisher
May 06, 2025

RA Capital Management L.P. Acquires Shares of 1,333,333 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 06, 2025
pulisher
May 05, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat

May 05, 2025
pulisher
May 04, 2025

Needham & Company LLC Reaffirms "Buy" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Darwin Global Management Ltd. Invests $3.08 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Schonfeld Strategic Advisors LLC Boosts Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 04, 2025
pulisher
May 03, 2025

Lord Abbett & CO. LLC Boosts Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat

May 03, 2025
pulisher
May 03, 2025

(NRIX) Trading Signals - news.stocktradersdaily.com

May 03, 2025
pulisher
May 02, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by T. Rowe Price Investment Management Inc. - MarketBeat

May 02, 2025

Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.16
price down icon 17.27%
$31.18
price down icon 3.94%
$578.71
price down icon 0.54%
$286.48
price down icon 0.94%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
Capitalizzazione:     |  Volume (24 ore):